Cost-Effectiveness of Betrixaban Compared With Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients With Acute Medical Illness in the United States
PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0757-8
Full Text
Open PDFAbstract
Available in full text
Date
December 21, 2018
Authors
Publisher
Springer Science and Business Media LLC